Published in J Natl Cancer Inst on June 01, 1984
Management of alimentary tract duplication in children. Br J Surg (1995) 2.26
Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA (1996) 1.27
Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice. Cancer Res (1975) 0.89
Suppression of humoral immune response in mice by administration of high molecular levan. Experientia (1978) 0.88
Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice. J Natl Cancer Inst (1980) 0.86
Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma. Cancer Res (1976) 0.83
Macrophage-recognized molecules of apoptotic cells are expressed at higher levels in AKR lymphoma of aged as compared to young mice. Adv Exp Med Biol (2000) 0.83
Effect of native levan on homograft rejection in mice. Proc Soc Exp Biol Med (1975) 0.81
The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice. Br J Cancer (1979) 0.81
Effect of levan on the stages of development of experimental allergic encephalomyelitis. Isr J Med Sci (1976) 0.81
Animal models for tumor progression (short review). Anticancer Res (1984) 0.81
A model for cancer treatment in advanced compared to early cancer. Anticancer Res (1987) 0.81
Inhibition of 3LL carcinoma of mice by levan treatment. Isr J Med Sci (1977) 0.80
Different biological behavior of AKR lymphoma cells from primary and metastatic tumors. Experientia (1985) 0.80
Inhibitory effeft of oxidized spermine on the multiplication of coliphage T5. J Mol Biol (1966) 0.80
Metastatic potential and multidrug resistance correlation in the B16 melanoma system. J Exp Ther Oncol (1996) 0.80
Histological criteria for immunological rejection of mouse skin homografts. J Pathol (1977) 0.79
Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs. Cancer Res (1984) 0.79
Mechanism of the inhibitory effect of levan on experimental tumors. Recent Results Cancer Res (1980) 0.79
Spontaneous AKR lymphomas differ in their degree of malignancy and sensitivity to the polysaccharide levan. Experientia (1983) 0.79
Comparison of growth rate of two B16 melanomas differing in metastatic potential in young versus middle-aged mice. Cancer Invest (1997) 0.79
Antiphage action of oxidized polyamines. Isr J Med Sci (1965) 0.78
Augmentative effects of intracellular chemotherapy penetration combined with hyperthermia in human ovarian cancer cells lines. Gynecol Oncol (1994) 0.78
Role of immune response as determinant of tumor progression in function of host age in the B16 melanoma. Mech Ageing Dev (1995) 0.78
Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan. Cell Tissue Res (1986) 0.77
Modification of the tuberculin reaction by levan. Br J Exp Pathol (1978) 0.77
Comparison of splenectomy effects as an indication for host response to growth of primary and metastatic tumour cells in two murine tumour systems. Int J Exp Pathol (1995) 0.77
Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines. J Neurooncol (1994) 0.77
Effect of hyperthermia and thermochemotherapy on primary and metastatic tumour cells of AKR lymphoma. Int J Exp Pathol (1990) 0.77
[Properties of threonine deaminase from wild type and a valine sensitive mutant of Bacillus subtilis]. Bull Soc Chim Biol (Paris) (1969) 0.77
T cell receptor Ddelta2Ddelta3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (1997) 0.77
Increase in cell permeability to a cytotoxic agent by the polysaccharide levan. Cell Mol Biol (1985) 0.77
Immunoglobulin kappa gene rearrangements between the kappa deleting element and Jkappa recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis. Leukemia (2000) 0.77
Effect of splenectomy on treatment of Lewis lung carcinoma by an immunomodulatory polysaccharide and a cytotoxic agent. J Surg Oncol (1987) 0.77
Lysis and growth stimulation of a murine melanoma determined by density of macrophage populations. Anticancer Res (1985) 0.76
Effect of lectins on tumorigenicity of AKR lymphoma cells of varying malignancy. Anticancer Res (1987) 0.76
Effect of splenectomy on the efficiency of chemo-immunotherapy of melanoma-bearing mice. Int J Immunopharmacol (1985) 0.76
Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program. Ann Neurol (1994) 0.75
Enhancing effect of ATP on intracellular adriamycin penetration in human ovarian cancer cell lines. Biochim Biophys Acta (1994) 0.75
Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma. Br J Exp Pathol (1986) 0.75
Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice. Br J Exp Pathol (1983) 0.75
[C. Influence of levan on the development of malignant tumors in mice]. Harefuah (1977) 0.75
Inhibitory and stimulatory effects of levan on growth of B16 melanoma--possible mechanisms. Cell Mol Biol (1985) 0.75
Apoptosis and cell proliferation capacity in AKR lymphoma malignancy variants. Cancer Invest (2000) 0.75
Apoptosis, cell proliferation and in vivo biological behaviour of primary and metastatic tumour cells of an AKR lymphoma variant. Apoptosis (1997) 0.75
Drug resistance and its counteraction by cyclosporin A in function of metastatic potential in the Lewis lung carcinoma system. Cell Mol Biol (Noisy-le-grand) (1994) 0.75
Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide. Anticancer Res (1985) 0.75
Cellular functions related to metastasis differing between low- and high-malignancy variants of AKR lymphoma. Pathobiology (1992) 0.75
Effect of hyperthermia on AKR lymphoma variants differing in degree of malignancy. Cancer Invest (2001) 0.75
Enhancement of cytotoxic agent accumulation by Doppler flow sonication of human ovarian cancer cells. Eur J Gynaecol Oncol (1994) 0.75
Successful contact sensitization to chromate in mice. Int Arch Allergy Appl Immunol (1988) 0.75
Metastasis-related cell functions in primary and metastatic tumor cells of AKR lymphoma. Cancer Lett (1996) 0.75
Sensitivity to macrophages decreases with tumor progression in the AKR lymphoma. Adv Exp Med Biol (2000) 0.75
Combined treatment of Lewis lung carcinoma by tumor excision and levan. Oncology (1981) 0.75
Apoptotic cell death and related gene expression in metastatic tumors of AKR lymphomas of varying malignancy. Apoptosis (1999) 0.75
Combined effect in vitro of chemotherapy with agents acting on the cell membrane of Lewis lung carcinoma. Chemotherapy (1990) 0.75
Effect of a membrane-active agent on uptake of adriamycin in Lewis lung carcinoma cells derived from 'primary' and 'metastatic' growths. Chemotherapy (1992) 0.75
Changes in distribution of lectin receptors in macrophages activated by Nocardia water soluble molecules. Cell Mol Biol (Noisy-le-grand) (1993) 0.75
Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes. Int J Immunopharmacol (1986) 0.75
AKR lymphoma malignancy variants differing at late phase of metastasis. Cancer Lett (1990) 0.75
A model for the study of the long duration pathogenesis of cancer and its relevance to therapy. Med Hypotheses (1983) 0.75
Bone marrow and peripheral blood modifications in C57BL mice administered with cyclophosphamide and levan. In Vivo (1992) 0.75
Slow cytotoxicity of the polysaccharide levan on tumor cells in vitro. Chem Biol Interact (1986) 0.75
Release from apoptosis correlates with tumor progression in the AKR lymphoma. Biochim Biophys Acta (2000) 0.75
Blood levels of high-molecular levan in mice as a function of the route and duration of administration. Arzneimittelforschung (1980) 0.75
Protective effect of native levan on endotoxin toxicity in mice and rats. Experientia (1979) 0.75
Histological study of homografts showing delayed rejection following levan administration. J Pathol (1978) 0.75
Metastasis-associated cell functions in AKR lymphoma malignancy variants. Invasion Metastasis (1995) 0.75
Effect of administration schedule on the levan-cyclophosphamide combined treatment of Lewis lung carcinoma. Int J Immunopharmacol (1983) 0.75
In vitro effect of levan-activated macrophages on Lewis lung carcinoma cells. Int J Immunopharmacol (1986) 0.75
Effect of local administration of levan on skin homograft rejection in mice. Proc Soc Exp Biol Med (1976) 0.75
Effect of levan on the fate of experimental hematogenous metastases of Lewis lung carcinoma. Exp Mol Pathol (1982) 0.75
Different stages of tumor development are unequally affected by pretreatment of tumor cells with a polysaccharide. Cancer Lett (1984) 0.75
Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers. Exp Cell Biol (1984) 0.75
Biological behavior and cell properties of new AKR lymphoma malignancy variants. Tissue Cell (1998) 0.75
Effect of levan on tumorigenicity of cells from different murine tumors. Cell Mol Biol (1984) 0.75